UNICALCIN 100 INJECTION

Common side effects of UNICALCIN 100 INJECTION may include nausea, vomiting, diarrhea, headache, flushing of the face or skin, injection site reactions (for injectable formulations), and nasal irritation or dryness (for nasal spray).

The duration of UNICALCIN 100 INJECTION use depends on the specific medical condition being treated and the healthcare provider's recommendation. In some cases, it is intended for short-term use only. Long-term use, especially for osteoporosis, may not be recommended due to concerns about its overall effectiveness and safety.

The safety and effectiveness of UNICALCIN 100 INJECTION in pediatric patients have not been well-established, and healthcare providers should carefully consider its use in children and adolescents. Elderly patients may be more susceptible to side effects, especially gastrointestinal disturbances, and dose adjustments may be necessary.

While UNICALCIN 100 INJECTION has been used to manage bone pain in some cancer patients, its role in chronic pain management is limited, and other treatments may be more effective and preferred.

If you miss a dose of UNICALCIN 100 INJECTION, follow the specific dosing instructions provided by your healthcare provider or the medication's packaging. Do not double the dose to catch up. If you are unsure about what to do, contact your healthcare provider or pharmacist for guidance.

UNICALCIN 100 INJECTION may transiently increase serum thyroglobulin levels, leading to temporary effects on thyroid function tests. If you are undergoing thyroid function testing, inform your healthcare provider that you are taking this medication to avoid misinterpreting test results.

There are no known significant interactions of UNICALCIN 100 INJECTION with other drugs. However, it is important to inform your healthcare provider about all the medications, supplements, and herbal products you are taking to avoid potential interactions.

Patients with a history of hypersensitivity reactions to UNICALCIN 100 INJECTION or its components should avoid its use. Caution is necessary for individuals with existing hypocalcemia or conditions that may predispose them to low calcium levels, as this medication can further lower blood calcium levels. Liver impairment may require dosage adjustments, and patients with certain malignancies should be carefully evaluated before using it. Its safety during pregnancy and breastfeeding has not been extensively studied, so caution is advised. Long-term use may be associated with developing tumor-induced osteomalacia and osteosarcoma (type of bone cancer) in rare cases. Regular monitoring and follow-up with healthcare providers are essential to ensure safe and effective use of this medication.

UNICALCIN 100 INJECTION is made of Calcitonin.

UNICALCIN 100 INJECTION is prescribed for ailments like Orthopaedics and Gynaecology.